ANNA JONES: Open Payments
NPI 1386192557 · GREENSBORO, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 14 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $20 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $97 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Corium, LLC | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
Products named: UBRELVY, LEQVIO, Jornay PM, CAPLYTA, Azstarys, REXULTI, FARXIGA, VRAYLAR.
Industry payments across AL — which companies pay providers there.
